Skip to main content
. 2020 Sep 1;22(3):200–211. doi: 10.1016/S1441-2772(23)00387-3

Table 1.

Clinical characteristics at hospital admission

Clinical characteristics Values
n (%)* Median (IQR)
Total number of patients 73
Duration from symptoms (days)
 To hospital admission 6.0 (4.0–10.0)
 To ICU admission 9.0 (7.0–13.0)
History of contact
Closed contact with a confirmed case 11 (15.1%)
Presence in a health care facility treating patients with COVID-19 3 (4.1%)
Vital signs
Awake 55/68 (80.9%)
Oriented 55/67 (82.1 %)
Temperature (°C) 38.0 (37.4–38.8)
Fever (temperature > 37.8°C) 34/59 (57.6%)
Spo2 (%) 94 (85–96)
 At room air 37/70 (50.7%) 94 (85–96)
 With oxygen supplementation 33/70 (45.2%) 93 (86–97)
Systolic blood pressure (mmHg) 129 (115–140)
Diastolic blood pressure (mmHg) 70 (60–80)
Heart rate (beats per min) 100 (86–113)
Respiratory rate (breaths per min) 28 (24–33)
 At room air 37/70 (50.7%) 31 (28–40)
 With oxygen supplementation 33/70 (45.2%) 28 (24–31)
History of symptoms
Fever in the previous 14 days 68/70 (97.1%)
Cough 43/57 (75.4%)
 With sputum production 6/40 (15.0%)
Sore throat 6/46 (13.0%)
Arthralgia 1/45 (2.2%)
Fatigue 9/47 (19.1%)
Shortness of breath 45/61 (73.8%)
Altered level of consciousness 1/46 (2.2%)
Imaging
Chest x-ray 73 (100.0%)
 Infiltrates 73 (100.0%)
Chest computed tomography 11 (15.1%)
 Interstitial pneumonia 11/11 (100.0%
Haemoglobin (g/dL) 13.4 (12.3–14.9)
White blood cell count (× 103 per mm3) 9.20 (5.65–11.95)
Lymphocyte count (× 103 per mm3) 0.77 (0.58–1.00)
Lymphocytopenia 44/60 (73.3%)
Total bilirubin (mg/dL) 0.6 (0.4–1.0)
Urea (mg/dL) 52.0 (33.5–77.5)
Creatinine (mg/dL) 1.10 (0.87–1.33)
Lactate (mmol/L) 1.5 (1.2–2.2)
C-reactive protein (mg/dL) 184.5 (108.2–269.1)

COVID-19 = coronavirus disease 2019; ICU = intensive care unit; IQR = interquartile range; Spo2 = oxygen saturation measured by pulse oximetry.

*

Percentages may not total 100 because of rounding.

To convert the values for creatinine to μmol/L, multiply by 88.4.